Literature DB >> 16946481

Crystallization and preliminary X-ray diffraction analysis of rat protein tyrosine phosphatase eta.

Huita C Matozo1, Alessandro S Nascimento, Maria A M Santos, Rodolfo Iuliano, Alfredo Fusco, Igor Polikarpov.   

Abstract

The rat protein tyrosine phosphatase eta (rPTPeta) is a cysteine-dependent phosphatase which hydrolyzes phosphoester bonds in proteins and other molecules. rPTPeta and its human homologue DEP-1 are involved in neoplastic transformations. Thus, expression of the protein is reduced in all oncogene-transformed thyroid cell lines and is absent in highly malignant thyroid cells. Moreover, consistent with the suggested tumour suppression role of PTPeta, inhibition of the tumorigenic process occurs after its exogenous reconstitution, suggesting that PTPeta might be important for gene therapy of cancers. In this study, the catalytic domain of rPTPeta was produced in Escherichia coli in soluble form and purified to homogeneity. Crystals were obtained by the hanging-drop vapour-diffusion method. Diffraction data were collected to 1.87 A resolution. The crystal belongs to space group P2(1)2(1)2(1), with unit-cell parameters a = 46.46, b = 63.07, c = 111.64 A, and contains one molecule per asymmetric unit.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16946481      PMCID: PMC2242866          DOI: 10.1107/S1744309106031058

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  26 in total

Review 1.  The catalytic mechanism of protein tyrosine phosphatases revisited.

Authors:  K Kolmodin; J Aqvist
Journal:  FEBS Lett       Date:  2001-06-08       Impact factor: 4.124

Review 2.  Protein tyrosine phosphorylation in T cell signaling.

Authors:  Tomas Mustelin; Robert T Abraham; Christopher E Rudd; Andres Alonso; Joseph J Merlo
Journal:  Front Biosci       Date:  2002-04-01

3.  Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1).

Authors:  F Trapasso; R Iuliano; A Boccia; A Stella; R Visconti; P Bruni; G Baldassarre; M Santoro; G Viglietto; A Fusco
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

5.  Crystal structure of Yersinia protein tyrosine phosphatase at 2.5 A and the complex with tungstate.

Authors:  J A Stuckey; H L Schubert; E B Fauman; Z Y Zhang; J E Dixon; M A Saper
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

Review 6.  Protein-tyrosine phosphatases in development.

Authors:  J den Hertog
Journal:  Mech Dev       Date:  1999-07       Impact factor: 1.882

7.  Protein tyrosine phosphatase-eta expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells.

Authors:  M L Martelli; F Trapasso; P Bruni; M T Berlingieri; C Battaglia; M T Vento; B Belletti; R Iuliano; M Santoro; G Viglietto; A Fusco
Journal:  Exp Cell Res       Date:  1998-11-25       Impact factor: 3.905

8.  Ptprj is a candidate for the mouse colon-cancer susceptibility locus Scc1 and is frequently deleted in human cancers.

Authors:  Claudia A L Ruivenkamp; Tom van Wezel; Carlo Zanon; Alphons P M Stassen; Cestmir Vlcek; Tamás Csikós; Anita M Klous; Nikos Tripodis; Anastassis Perrakis; Lucie Boerrigter; Peter C Groot; Jan Lindeman; Wolter J Mooi; Gerrit A Meijjer; Gert Scholten; Hans Dauwerse; Vaclav Paces; Nico van Zandwijk; Gert Jan B van Ommen; Peter Demant
Journal:  Nat Genet       Date:  2002-06-24       Impact factor: 38.330

9.  On the choice of an optimal wavelength in macromolecular crystallography.

Authors:  A Teplyakov; G Oliva; I Polikarpov
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1998-07-01

10.  The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells.

Authors:  K Okazaki; N Sagata
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.